Recombinant EGFR (Tomuzotuximab Biosimilar) antibody

Catalog No. ABIN7538076

The Human Chimeric anti-EGFR (Tomuzotuximab Biosimilar) antibody is suitable to detect EGFR (Tomuzotuximab Biosimilar) in samples from Human. It has been validated for ELISA and WB.

Quick Overview for Recombinant EGFR (Tomuzotuximab Biosimilar) antibody (ABIN7538076)

Target: EGFR (Tomuzotuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human, Mouse

Clonality: Chimeric

Conjugate: This EGFR (Tomuzotuximab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-EGFR (Tomuzotuximab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Tomuzotuximab Biosimilar - Anti-EGFR mAb - Research Grade

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer PH7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for EGFR (Tomuzotuximab Biosimilar)

Target: EGFR (Tomuzotuximab Biosimilar)

Target Type: Biosimilar

Background: Tomuzotuximab (Anti-Human EGFR Recombinant Antibody) is a fully human glycoengineered IgG1 monoclonal antibody against EGFR. Tomuzotuximab has anticancer effects.

CAS-No: 1646321-00-7